In a recent prospective cohort study on patients with PAD, CAD, or both, rates of all-cause mortality and MACE increased with increasing MPO levels, whereas MPO was associated with rates of limb ischemia and further revascularization in patients with PAD. Here, MPO is linked to coronary artery disorder.